Firefly Luciferase mRNA: Assay Workflow

2026-09-21

Build more interpretable transfection, gene expression, cell viability, and imaging studies with a chemically optimized bioluminescent reporter. This workflow connects practical handling of Firefly Luciferase mRNA with delivery benchmarking and translational mRNA research.

Nutlin-3a and the Next Logic of p53 Translation

2026-09-20

Nutlin-3a offers a precise way to interrogate MDM2–p53 biology while opening a translational conversation about ferroptosis, migration, and treatment strategy in glioblastoma. This article connects target engagement with experimental design, model selection, and clinically relevant decision points.

FITC Goat Anti-Mouse IgG (H+L) Antibody Guide

2026-09-19

This fluorescein-conjugated secondary antibody provides fluorescent detection of mouse IgG primary antibodies in immunofluorescence, microscopy, and flow cytometry workflows. It is intended for research assay development and optimization, not as a standalone reagent for detecting non-mouse immunoglobulins or as evidence of a validated clinical diagnostic procedure.

BMPSB4 Activates Autophagy in Corticotroph PitNETs

2026-09-18

A 2024 study identifies BMPSB4 as a pharmacological agonist of deficient BMP4 signaling in corticotroph pituitary neuroendocrine tumors. Using transcriptomic, imaging, cellular, and animal-model evidence, the authors link BMP4/SMAD1/5/9 activation to autophagy-mediated tumor suppression and reduced ACTH and corticosterone output.

Sodium Ascorbate: From ROS Biology to Translation

2026-09-18

A translational perspective on how Sodium Ascorbate can support reproducible ROS-driven cancer research, while biomarker-led models such as circulating GPNMB illustrate the requirements for moving from tumor-cell phenotypes toward precision study design.

Cabozantinib (XL184) in RCC Research Workflows

2026-09-17

Cabozantinib (XL184) supports more than endpoint viability assays: it enables time-resolved studies of RTK suppression, angiogenesis, phosphoproteomic remodeling, and motility adaptation. This workflow translates acute-versus-chronic exposure findings into practical renal cell carcinoma and endothelial assay designs.

Cabozantinib (XL184) RCC Research Workflow

2026-09-17

Build reproducible Cabozantinib experiments that separate acute kinase suppression from chronic adaptation in renal cell carcinoma. This workflow combines phosphoproteomics, MET validation, motility assays, and angiogenesis readouts to turn a multi-target inhibitor into a practical systems-biology tool.

AAL-993: A Decision Framework for Angiogenesis Assays

2026-09-16

AAL-993 is a VEGF receptor inhibitor suited to mechanistically layered angiogenesis studies. This article shows how to connect receptor-level potency, endothelial phenotypes, tumor-model outcomes, and network-pharmacology insights without overstating cross-domain evidence.

Angiotensin (1-7) Experimental Workflows

2026-09-16

Build reproducible Mas-receptor experiments with a defined heptapeptide sequence, practical dosing benchmarks, and assay-ready handling guidance. From renal fibrosis models to receptor-binding studies, this workflow connects mechanism, controls, and troubleshooting without overstating translational evidence.

Reserpine (N1867): Practical Lab Workflow

2026-09-15

Reserpine (SKU N1867) provides a characterized research reagent for controlled neurotransmitter depletion research, antihypertensive mechanism studies, and related neuropharmacology research. This guide addresses identity, solubility, storage, solution preparation, and QC; the compound is for research use only and should not be used for diagnostic, therapeutic, or medical applications.

Crizotinib Hydrochloride in ALK Research

2026-09-15

Crizotinib hydrochloride is an ATP-competitive ALK kinase inhibitor that also targets c-Met and ROS1. Its defined kinase-phosphorylation effects make it useful for cancer biology research, including controlled studies in patient-derived tumor–stroma models.

Preserving Protein Truth in Mitocytosis Research

2026-09-14

Mitocytosis research shows why biological interpretation depends on rigorous protein preservation. This thought-leadership guide connects mitochondrial stress biology with practical sample-preparation strategy, highlighting how an EDTA-free inhibitor cocktail can protect phosphorylation-sensitive and native-protein workflows without overstating preclinical findings.

Fzd5 Links Cholesterol to Wnt Signaling

2026-09-14

Fzd5 Cholesterol Sensing Drives Wnt Signaling in Cancer

2026-09-13

The reference study identifies Frizzled5 as a cholesterol-sensing Wnt receptor that links lipid metabolism to receptor palmitoylation, plasma-membrane trafficking, and pancreatic cancer growth. Its findings provide a mechanistic framework for studying cholesterol-sensitive Wnt signaling and suggest that disrupting the Fzd5–cholesterol interface may be relevant in Wnt-dependent malignancies.

AZD1390: ATM Kinase Inhibitor Workflows

2026-09-12

AZD1390 supports mechanism-guided studies of ATM signaling, radiation response, and replication stress across glioma and lung cancer models. This workflow connects nanomolar ATM inhibition with practical assay design and emerging REV1–DHX36 G-quadruplex biology.